Affiliation
Dermatology Unit, St George's University of London, London, UK.Issue Date
2020
Metadata
Show full item recordAbstract
Basal cell carcinoma (BCC) followed by squamous cell carcinoma (SCC) are the two commonest cancers in white populations worldwide.1 While sharing some features, they are distinct clinically and pathologically and thus the ratio of BCC to SCC incidence rates serves as a useful composite that enables immediate comparisons of trends within and between populations. There is a widely held belief that the BCC:SCC ratio sits relatively constantly at around 4:1 in the general population, though this belief has little apparent basis.Citation
Jiyad Z, Marquart L, Green AC. A Call to Standardise the BCC:SCC Ratio. Br J Dermatol. 2020.Journal
British Journal of DermatologyDOI
10.1111/bjd.19550PubMed ID
32920840Additional Links
https://dx.doi.org/10.1111/bjd.19550Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.1111/bjd.19550
Scopus Count
Collections
Related articles
- Response to 'A call to standardize the BCC:SCC ratio'.
- Authors: Ma BC, Sahni VN, Edwards LD, Sahni DR, Secrest AM
- Issue date: 2021 Oct
- Diagnostic value of CD10 and Bcl2 expression in distinguishing cutaneous basal cell carcinoma from squamous cell carcinoma and seborrheic keratosis.
- Authors: Gaballah MA, Ahmed RA
- Issue date: 2015 Dec
- Clinical triage of cutaneous squamous cell carcinoma and basal cell carcinoma to avoid treatment delay: value of an electronic booking system.
- Authors: Fremlin GA, Bray AP, de Berker DA
- Issue date: 2014 Aug
- Response to 'A call to standardize the BCC:SCC ratio': reply from the authors.
- Authors: Jiyad Z, Marquart L, Green AC
- Issue date: 2021 Oct
- What is your skin cancer IQ? Identifying BCC, SCC, and melanoma.
- Issue date: 2007 May